The domestic pharmaceutical industry is facing many challenges, as an excellent enterprise model with strong comprehensive strength, listed pharmaceutical companies not only have a great role in promoting the development of the industry, but also have a certain reference significance for the development of other pharmaceutical companies. Accelerating the innovation and development of China's pharmaceutical industry and promoting the industry to the high-end of international industry is the requirement of The Times, and it is also an urgent requirement to promote the construction of healthy China and achieve sustainable development. In this closed-door meeting, the founders, chairmen or general managers of nearly 30 listed pharmaceutical companies gathered together to share wonderful views on industry trends, development strategies, business layout and other aspects.
2023 Annual Conference of API Entrepreneurs
In 2023, the API industry faces a series of problems such as overseas order transfer, low-cost competition in India and overcapacity caused by the decline in demand in the post-epidemic era, reshuffling and reshaping have become the main theme of the industry, we need to change our thinking in time, abandon the traditional mode of competition, and cooperate to create a new bureau.
On August 3-4, the fourth Annual Meeting of China API Entrepreneurs (the fifth CMC-China Pharmaceutical Expo sub-forum) was held in Suzhou, inviting the founders, chairmen or general managers of nearly 30 listed API companies to deeply discuss the industry development trend, incremental opportunities, strategic layout, opportunities and challenges to go to sea and other important topics. At the same time, we actively helped everyone to connect resources.
